During the past decade, Polyclinic Tor Vergata conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinic Tor Vergata" #1 collaborator was "Regina Elena Cancer Institute" with 1 trials as a collaborator and "University of Rome Tor Vergata" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinic Tor Vergata" are "Crohn Disease" (3 trials), "Leukemia, Myeloid, Acute" (1 trials), "Melanoma" (1 trials), "Palmoplantar Psoriasis" (1 trials) and "Pleural Effusion" (1 trials). Many other conditions were trialed in "Polyclinic Tor Vergata" in a lesser frequency.

Most popular intervention types in "Polyclinic Tor Vergata" are "Drug" (4 trials), "Other" (3 trials), "Device" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (3 trials), "Placebo" (3 trials), "Standard cloth" (2 trials), "TEPSO cloth" (2 trials) and "Awake VATS talc pleurodesis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinic Tor Vergata" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Polyclinic Tor Vergata". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Polyclinic Tor Vergata, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinic Tor Vergata, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".